|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 9.840 USD | +1.97% |
|
-0.61% | +26.15% |
| 06-29 | BioCryst scraps internal drug discovery programs, leans on partnerships to cut costs | RE |
| 06-29 | BioCryst to Discontinue Internal Discovery Programs, Close Birmingham Facility by Year-End | MT |
Main competitors
| Change | 5-day change | 1-month change | 3-month change | YTD change | 1-year change | 3-year change | 5-year change | 10-year change | Capi.($) | ||
|---|---|---|---|---|---|---|---|---|---|---|---|
 | +1.97% | -0.61% | +17.99% | +9.09% | +26.15% | +9.09% | +39.77% | -40.29% | +234.69% | 2.45B | |
| +3.98% | +5.55% | +18.90% | +27.50% | +15.12% | +76.40% | +132.19% | +214.48% | +6,911.05% | 56.21B | |
| -3.12% | +3.48% | +21.60% | +17.55% | +33.83% | +72.79% | +94.67% | -21.77% | - | 55.38B | |
| +3.86% | +8.38% | +9.43% | +6.98% | +2.46% | -9.90% | -9.62% | -56.45% | - | 23.75B | |
| +4.30% | +6.82% | +7.59% | -31.29% | -35.88% | +13.60% | +428.91% | +291.58% | +1,006.05% | 23.19B | |
| +3.64% | +8.34% | +2.05% | +2.52% | +14.06% | +39.81% | -4.50% | -74.29% | - | 18.14B | |
| +4.11% | +8.89% | +21.33% | +6.57% | -7.55% | +44.60% | -27.36% | -28.01% | +51.50% | 16.84B | |
| +2.57% | +16.74% | +54.66% | +120.73% | +196.81% | +171.12% | +355.99% | +1,663.18% | +662.64% | 15.86B | |
| +3.50% | +4.92% | +15.06% | +27.28% | +27.42% | +26.07% | +192.26% | +205.86% | +583.60% | 13.56B | |
| +7.20% | +13.33% | +15.86% | -7.13% | +19.22% | +42.13% | - | - | - | 12.97B | |
| +2.67% | +2.79% | +16.61% | -3.44% | -9.31% | +75.95% | +128.61% | +433.43% | - | 11.86B | |
| +1.44% | +7.04% | +21.97% | +29.61% | +36.12% | +151.72% | +165.14% | +319.65% | +795.34% | 11.58B | |
| +4.41% | +5.95% | +18.60% | +37.62% | +26.51% | +396.98% | +135.53% | +33.04% | +1,427.09% | 11.33B | |
| +7.23% | +8.74% | +3.77% | -20.43% | -11.84% | -31.83% | +514.34% | +98.97% | +98.46% | 11.16B | |
| +7.67% | +10.94% | -10.99% | -32.53% | -16.11% | +2.16% | +168.18% | +59.06% | - | 10.34B | |
| +0.11% | +0.16% | +35.45% | +17.36% | +23.00% | +53.70% | +193.41% | - | - | 9.76B | |
| +2.61% | +21.18% | +30.57% | +29.32% | +376.77% | +257.58% | +239.57% | -32.52% | - | 9.64B | |
| +7.74% | +14.28% | +4.37% | -30.51% | +11.18% | +44.89% | +133.72% | -31.11% | - | 9.21B | |
| +4.12% | +8.77% | +23.16% | +0.02% | +26.55% | +75.50% | +16.92% | +156.21% | - | 8.1B | |
| -2.54% | -2.30% | +25.26% | +82.07% | +164.44% | +458.90% | +669.19% | -50.71% | -28.55% | 7.72B | |
| Average | +3.37% | +6.74% | +17.66% | +14.44% | +45.95% | +98.56% | +187.73% | +174.46% | +1,174.19% | 16.95B | |
| Weighted average by Cap. | +2.75% | +6.67% | +17.79% | +15.62% | +34.32% | +82.32% | +163.71% | +173.00% | +2,695.15% |
- Stock Market
- Stocks
- BCRX Stock
- Sector BioCryst Pharmaceuticals, Inc.
Select your edition
All financial news and data tailored to specific country editions
